Poster Session D - Tuesday Morning
Category: Small Intestine
Olivia Lanser, MD
University of Chicago Medical Center
Chicago, IL
| Negative VCE (n = 45) | Positive VCE (n =37) | P-value |
Age, years, mean (SD) | 63.6 (15.8) | 68.6 (9.3) | 0.303 |
Male sex, n (%) | 21 (46.7) | 17 (46) | 1 |
White race, n (%) | 22 (48.9) | 20 (54.1) | 0.223 |
Active smoking, n (%) | 6 (14) | 11 (29.7) | 0.105 |
Outpatient location, n (%) | 31 (68.9) | 21 (56.8) | 0.357 |
Chronic kidney disease, n (%) | 10 (22.2) | 13 (35.1) | 0.224 |
Chronic liver disease, n (%) | 3 (6.7) | 4 (10.8) | 0.696 |
Congestive heart failure, n (%) | 10 (22.2) | 13 (35.1) | 0.224 |
Diabetes mellitus, n (%) | 15 (33.3) | 15 (40.5) | 0.645 |
Cardiac valvular disease, n (%) | 7 (15.6) | 6 (16.2) | 1 |
Coronary artery disease, n (%) | 14 (31.1) | 14 (37.8) | 0.641 |
Cardiac arrhythmia, n (%) | 10 (22.2) | 18 (48.7) | 0.019 |
Chronic lung disease, n (%) | 10 (22.2) | 13 (35.1) | 0.224 |
Left ventricular assist device, n (%) | 2 (4.4) | 2 (5.4) | 1 |
Blood transfusion in the preceding 4 weeks, n (%) | 17 (37.8) | 16 (43.2) | 0.656 |
Aspirin, n (%) | 20 (44.4) | 14 (37.8) | 0.654 |
Thienopyridine, n (%) | 3 (6.7) | 2 (5.4) | 1 |
Coumadin, n (%) | 1 (2.2) | 5 (13.5) | 0.086 |
SSRI/SNRI, n (%) | 7 (15.6) | 9 (24.3) | 0.404 |
ACEi | 7 (15.6) | 15 (40.5) | 0.014 |
ARB | 9 (20) | 7 (18.9) | 1 |
Hemoglobin, g/dL1 | 9.9 (1.7) | 9.2 (2.3) | 0.216 |
Platelets, 109/L1 | 225.4 (67.5) | 208.6 (84.9) | 0.202 |
BUN, mg/dL1 | 21.9 (13.1) | 26.7 (22) | 0.869 |
Creatinine, mg/dL1 | 1.3 (0.5) | 1.9 (1.5) | 0.197 |
Ferritin, ng/mL,1 | 128 (259) | 39.6 (28.7) | 0.966 |
Percent saturation, %1 | 14.8 (15.1) | 13.7 (15.4) | 0.76 |